{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:02:23Z","timestamp":1791219743277,"version":"4.1.0"},"reference-count":47,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutational activation of the K-Ras oncogene is well established as a key genetic step in the development and growth of pancreatic adenocarcinomas. However, the mechanism by which aberrant Ras signaling promotes uncontrolled pancreatic tumor cell growth remains to be fully elucidated. The recent use of primary human cells to study Ras-mediated oncogenesis provides important model cell systems to dissect this mechanism. We have used a model of telomerase-immortalized human pancreatic duct-derived cells (E6\/E7\/st) to study mechanisms of Ras growth transformation. First, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras(12D) growth transformation. Second, K-Ras(12D) caused growth transformation in vitro, including enhanced growth rate and loss of density dependency for growth, anchorage independence, and invasion through reconstituted basement membrane proteins, and tumorigenic transformation in vivo. Third, we determined that the Raf, phosphatidylinositol 3-kinase (PI3K), and Ral guanine nucleotide exchange factor effector pathways were activated, although extracellular signal-regulated kinase (ERK) activity was not up-regulated persistently. Finally, pharmacologic inhibition of Raf\/mitogen-activated protein kinase\/ERK and PI3K signaling impaired K-Ras\u2013induced anchorage-independent growth and invasion. In summary, our studies established, characterized, and validated E6\/E7\/st cells for the study of Ras-induced oncogenesis. [Cancer Res 2007;67(5):2098\u2013106]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3752","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T03:03:59Z","timestamp":1172804639000},"page":"2098-2106","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":193,"title":["K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase Signaling"],"prefix":"10.1158","volume":"67","author":[{"given":"Paul M.","family":"Campbell","sequence":"first","affiliation":[{"name":"1Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Groehler","sequence":"additional","affiliation":[{"name":"1Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang M.","family":"Lee","sequence":"additional","affiliation":[{"name":"2Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"Ouellette","sequence":"additional","affiliation":[{"name":"2Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Khazak","sequence":"additional","affiliation":[{"name":"3NexusPharma, Inc., Langhorne, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channing J.","family":"Der","sequence":"additional","affiliation":[{"name":"1Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"2022061623230874500_B1","doi-asserted-by":"crossref","unstructured":"Maitra A, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol\u20082006; 20: 211\u201326.","DOI":"10.1016\/j.bpg.2005.10.002"},{"key":"2022061623230874500_B2","doi-asserted-by":"crossref","unstructured":"Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer\u20082003; 3: 459\u201365.","DOI":"10.1038\/nrc1097"},{"key":"2022061623230874500_B3","doi-asserted-by":"crossref","unstructured":"Cox AD, Der CJ. Ras family signaling: therapeutic targeting. Cancer Biol Ther\u20082002; 1: 599\u2013606.","DOI":"10.4161\/cbt.306"},{"key":"2022061623230874500_B4","doi-asserted-by":"crossref","unstructured":"Repasky GA, Chenette EJ, Der CJ. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol\u20082004; 14: 639\u201347.","DOI":"10.1016\/j.tcb.2004.09.014"},{"key":"2022061623230874500_B5","doi-asserted-by":"crossref","unstructured":"Rangarajan A, Hong SJ, Gifford A, Weinberg RA. Species- and cell type-specific requirements for cellular transformation. Cancer Cell\u20082004; 6: 171\u201383.","DOI":"10.1016\/j.ccr.2004.07.009"},{"key":"2022061623230874500_B6","unstructured":"Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature\u20082002; 417: 949\u201354."},{"key":"2022061623230874500_B7","doi-asserted-by":"crossref","unstructured":"Lim KH, O'Hayer K, Adam SJ, et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol\u20082006; 16: 2385\u201394.","DOI":"10.1016\/j.cub.2006.10.023"},{"key":"2022061623230874500_B8","doi-asserted-by":"crossref","unstructured":"Lim KH, Baines AT, Fiordalisi JJ, et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell\u20082005; 7: 533\u201345.","DOI":"10.1016\/j.ccr.2005.04.030"},{"key":"2022061623230874500_B9","doi-asserted-by":"crossref","unstructured":"Yip-Schneider MT, Lin A, Barnard D, Sweeney CJ, Marshall MS. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Int J Oncol\u20081999; 15: 271\u20139.","DOI":"10.3892\/ijo.15.2.271"},{"key":"2022061623230874500_B10","doi-asserted-by":"crossref","unstructured":"Hingorani SR, Wang L, Multani AS, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell\u20082005; 7: 469\u201383.","DOI":"10.1016\/j.ccr.2005.04.023"},{"key":"2022061623230874500_B11","doi-asserted-by":"crossref","unstructured":"Tuveson DA, Zhu L, Gopinathan A, et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res\u20082006; 66: 242\u20137.","DOI":"10.1158\/0008-5472.CAN-05-2305"},{"key":"2022061623230874500_B12","doi-asserted-by":"crossref","unstructured":"Muller-Decker K, Furstenberger G, Annan N, et al. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice. Gastroenterology\u20082006; 130: 2165\u201378.","DOI":"10.1053\/j.gastro.2006.03.053"},{"key":"2022061623230874500_B13","unstructured":"Liao DJ, Wang Y, Wu J, et al. Characterization of pancreatic lesions from MT-tgf\u03b1, Ela-myc, and MT-tgf\u03b1\/Ela-myc single and double transgenic mice. J Carcinog\u20082006; 5: 19."},{"key":"2022061623230874500_B14","doi-asserted-by":"crossref","unstructured":"Rangarajan A, Weinberg RA. Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer\u20082003; 3: 952\u20139.","DOI":"10.1038\/nrc1235"},{"key":"2022061623230874500_B15","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell\u20082002; 2: 243\u20137.","DOI":"10.1016\/S1535-6108(02)00122-8"},{"key":"2022061623230874500_B16","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science\u20082002; 296: 550\u20133.","DOI":"10.1126\/science.1068999"},{"key":"2022061623230874500_B17","doi-asserted-by":"crossref","unstructured":"Zhao JJ, Roberts TM, Hahn WC. Functional genetics and experimental models of human cancer. Trends Mol Med\u20082004; 10: 344\u201350.","DOI":"10.1016\/j.molmed.2004.05.005"},{"key":"2022061623230874500_B18","doi-asserted-by":"crossref","unstructured":"Counter CM, Hahn WC, Wei W, et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A\u20081998; 95: 14723\u20138.","DOI":"10.1073\/pnas.95.25.14723"},{"key":"2022061623230874500_B19","doi-asserted-by":"crossref","unstructured":"Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature\u20081999; 400: 464\u20138.","DOI":"10.1038\/22780"},{"key":"2022061623230874500_B20","doi-asserted-by":"crossref","unstructured":"Lundberg AS, Randell SH, Stewart SA, et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene\u20082002; 21: 4577\u201386.","DOI":"10.1038\/sj.onc.1205550"},{"key":"2022061623230874500_B21","unstructured":"Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol\u20081996; 148: 1763\u201370."},{"key":"2022061623230874500_B22","doi-asserted-by":"crossref","unstructured":"Jesnowski R, Muller P, Schareck W, Liebe S, Lohr M. Immortalized pancreatic duct cells in vitro and in vivo. Ann N Y Acad Sci\u20081999; 880: 50\u201365.","DOI":"10.1111\/j.1749-6632.1999.tb09509.x"},{"key":"2022061623230874500_B23","doi-asserted-by":"crossref","unstructured":"Lee KM, Nguyen C, Ulrich AB, Pour PM, Ouellette MM. Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem Biophys Res Commun\u20082003; 301: 1038\u201344.","DOI":"10.1016\/S0006-291X(03)00086-X"},{"key":"2022061623230874500_B24","doi-asserted-by":"crossref","unstructured":"Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol\u20081998; 153: 263\u20139.","DOI":"10.1016\/S0002-9440(10)65567-8"},{"key":"2022061623230874500_B25","doi-asserted-by":"crossref","unstructured":"Ouyang H, Mou L, Luk C, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol\u20082000; 157: 1623\u201331.","DOI":"10.1016\/S0002-9440(10)64800-6"},{"key":"2022061623230874500_B26","doi-asserted-by":"crossref","unstructured":"Qian J, Niu J, Li M, Chiao PJ, Tsao MS. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res\u20082005; 65: 5045\u201353.","DOI":"10.1158\/0008-5472.CAN-04-3208"},{"key":"2022061623230874500_B27","doi-asserted-by":"crossref","unstructured":"Greten FR, Wagner M, Weber CK, Zechner U, Adler G, Schmid RM. TGF \u03b1 transgenic mice. A model of pancreatic cancer development. Pancreatology\u20082001; 1: 363\u20138.","DOI":"10.1159\/000055835"},{"key":"2022061623230874500_B28","doi-asserted-by":"crossref","unstructured":"Wagner M, Luhrs H, Kloppel G, Adler G, Schmid RM. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology\u20081998; 115: 1254\u201362.","DOI":"10.1016\/S0016-5085(98)70098-8"},{"key":"2022061623230874500_B29","doi-asserted-by":"crossref","unstructured":"Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF \u03b1-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell\u20082003; 3: 565\u201376.","DOI":"10.1016\/S1535-6108(03)00140-5"},{"key":"2022061623230874500_B30","doi-asserted-by":"crossref","unstructured":"Lee KM, Yasuda H, Hollingsworth MA, Ouellette MM. Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Lab Invest\u20082005; 85: 1003\u201312.","DOI":"10.1038\/labinvest.3700298"},{"key":"2022061623230874500_B31","doi-asserted-by":"crossref","unstructured":"Peterson SN, Trabalzini L, Brtva TR, et al. Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J Biol Chem\u20081996; 271: 29903\u20138.","DOI":"10.1074\/jbc.271.47.29903"},{"key":"2022061623230874500_B32","doi-asserted-by":"crossref","unstructured":"Kato-Stankiewicz J, Hakimi I, Zhi G, et al. Inhibitors of Ras\/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Proc Natl Acad Sci U S A\u20082002; 99: 14398\u2013403.","DOI":"10.1073\/pnas.222222699"},{"key":"2022061623230874500_B33","doi-asserted-by":"crossref","unstructured":"Lyons JF, Wilhelm S, Hibner B, Bollag G. Discovery of a novel Raf kinase inhibitor. Endocr Relat Cancer\u20082001; 8: 219\u201325.","DOI":"10.1677\/erc.0.0080219"},{"key":"2022061623230874500_B34","doi-asserted-by":"crossref","unstructured":"Wolthuis RM, Zwartkruis F, Moen TC, Bos JL. Ras-dependent activation of the small GTPase Ral. Curr Biol\u20081998; 8: 471\u20134.","DOI":"10.1016\/S0960-9822(98)70183-6"},{"key":"2022061623230874500_B35","doi-asserted-by":"crossref","unstructured":"Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods\u20082005; 37: 208\u201315.","DOI":"10.1016\/j.ymeth.2005.08.001"},{"key":"2022061623230874500_B36","doi-asserted-by":"crossref","unstructured":"Elenbaas B, Spirio L, Koerner F, et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev\u20082001; 15: 50\u201365.","DOI":"10.1101\/gad.828901"},{"key":"2022061623230874500_B37","doi-asserted-by":"crossref","unstructured":"Hahn WC, Dessain SK, Brooks MW, et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol\u20082002; 22: 2111\u201323.","DOI":"10.1128\/MCB.22.7.2111-2123.2002"},{"key":"2022061623230874500_B38","doi-asserted-by":"crossref","unstructured":"Yip-Schneider MT, Lin A, Marshall MS. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun\u20082001; 280: 992\u20137.","DOI":"10.1006\/bbrc.2001.4243"},{"key":"2022061623230874500_B39","doi-asserted-by":"crossref","unstructured":"Avruch J, Zhang XF, Kyriakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci\u20081994; 19: 279\u201383.","DOI":"10.1016\/0968-0004(94)90005-1"},{"key":"2022061623230874500_B40","doi-asserted-by":"crossref","unstructured":"Marshall MS. Ras target proteins in eukaryotic cells. FASEB J\u20081995; 9: 1311\u20138.","DOI":"10.1096\/fasebj.9.13.7557021"},{"key":"2022061623230874500_B41","doi-asserted-by":"crossref","unstructured":"Janssens V, Goris J, Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev\u20082005; 15: 34\u201341.","DOI":"10.1016\/j.gde.2004.12.004"},{"key":"2022061623230874500_B42","doi-asserted-by":"crossref","unstructured":"Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell\u20082004; 5: 127\u201336.","DOI":"10.1016\/S1535-6108(04)00026-1"},{"key":"2022061623230874500_B43","doi-asserted-by":"crossref","unstructured":"Kendall SD, Linardic CM, Adam SJ, Counter CM. A network of genetic events sufficient to convert normal human cells to a tumorigenic state. Cancer Res\u20082005; 65: 9824\u20138.","DOI":"10.1158\/0008-5472.CAN-05-1543"},{"key":"2022061623230874500_B44","doi-asserted-by":"crossref","unstructured":"Zhao JJ, Gjoerup OV, Subramanian RR, et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell\u20082003; 3: 483\u201395.","DOI":"10.1016\/S1535-6108(03)00088-6"},{"key":"2022061623230874500_B45","doi-asserted-by":"crossref","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell\u20081997; 88: 593\u2013602.","DOI":"10.1016\/S0092-8674(00)81902-9"},{"key":"2022061623230874500_B46","doi-asserted-by":"crossref","unstructured":"Tuveson DA, Shaw AT, Willis NA, et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell\u20082004; 5: 375\u201387.","DOI":"10.1016\/S1535-6108(04)00085-6"},{"key":"2022061623230874500_B47","doi-asserted-by":"crossref","unstructured":"Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer\u20082004; 4: 937\u201347.","DOI":"10.1038\/nrc1503"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/2098\/2867840\/2098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/2098\/2867840\/2098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:17:21Z","timestamp":1655421441000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/5\/2098\/534020\/K-Ras-Promotes-Growth-Transformation-and-Invasion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3752","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1068798.521729","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}